Introduction/objectives Eosinophilic granulomatosis with polyangiitis (EGPA) is a necrotizing vasculitis that frequently affects small arteries in the skin and the nerve but can also involve the medium-sized arteries, resembling polyarteritis nodosa (PAN). This study aimed to evaluate the clinical value of biomarkers in EGPA in relation to the size of the affected arteries. Method In an inception cohort of EGPA, we examined the relationships between eosinophil counts, myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) positivity, levels of rheumatoid factor (RF) and Immunoglobulin E (IgE) and pre-defined outcomes based on artery size. These outcomes included histologically confirmed cutaneous vasculitis, glomerulonephritis, PAN-like arteritis in the cranial and abdominal arteries, and cardiomyopathy. Results IgE levels were significantly elevated in patients with cutaneous vasculitis and cardiomyopathy compared to those without the respective conditions. The median IgE values (range) were 3620 IU/mL (1160–6520) vs. 1000 IU/mL (229–5490) for cutaneous vasculitis (p = 0.0077), and 4065 IU/mL (1320–6520) vs. 1205 IU/mL (229–4030) for cardiomyopathy (p = 0.032). A numerically higher frequency of MPO-ANCA was observed in cases with PAN-like arteritis compared to those without (4/5 vs 8/25), similar to the findings for MPO-ANCA in glomerulonephritis. The crude odds ratio of MPO-ANCA positivity for both glomerulonephritis and PAN-like arteritis was 8.50 (95% CI: 1.05–181.45). The optimal IgE thresholds for detecting cutaneous vasculitis and cardiomyopathy were 1860 IU/mL and 2465 IU/mL, respectively, with areas under the curve of 0.82 and 0.84, indicating favorable diagnostic performance. Conclusions IgE levels were associated with cutaneous vasculitis and cardiomyopathy in an inception cohort of EGPA in Japan. Further studies with larger cohorts are needed to confirm these findings, as our results are based on a retrospective study with a small sample size. <Table Float="No" ID="Taba"> <tgroup cols="1"> <colspec align="left" colname="c1" colnum="1" /> <tbody> <row> <entry align="left" colname="c1"> Key Points </entry> </row> <row> <entry align="left" colname="c1"> • IgE levels were associated with cutaneous vasculitis in EGPA. • IgE levels were associated with cardiomyopathy in EGPA. • PAN-like arteritis tended to be associated with MPO-ANCA positivity. </entry> </row> </tbody> </tgroup> </Table>

Clinical value of biomarkers in relation to artery size in eosinophilic granulomatosis with polyangiitis: findings from an inception cohort at a Japanese City Hospital

期刊论文
发表日期：

2025年8月18日

查看全文

Hiroshi Oiwa,
Akihiro Yahata,
Naoki Nakamoto

摘要

Introduction/objectives

Eosinophilic granulomatosis with polyangiitis (EGPA) is a necrotizing vasculitis that frequently affects small arteries in the skin and the nerve but can also involve the medium-sized arteries, resembling polyarteritis nodosa (PAN). This study aimed to evaluate the clinical value of biomarkers in EGPA in relation to the size of the affected arteries.

Method

In an inception cohort of EGPA, we examined the relationships between eosinophil counts, myeloperoxidase-antineutrophil cytoplasmic antibody (MPO-ANCA) positivity, levels of rheumatoid factor (RF) and Immunoglobulin E (IgE) and pre-defined outcomes based on artery size. These outcomes included histologically confirmed cutaneous vasculitis, glomerulonephritis, PAN-like arteritis in the cranial and abdominal arteries, and cardiomyopathy.

Results

IgE levels were significantly elevated in patients with cutaneous vasculitis and cardiomyopathy compared to those without the respective conditions. The median IgE values (range) were 3620 IU/mL (1160–6520) vs. 1000 IU/mL (229–5490) for cutaneous vasculitis (p = 0.0077), and 4065 IU/mL (1320–6520) vs. 1205 IU/mL (229–4030) for cardiomyopathy (p = 0.032). A numerically higher frequency of MPO-ANCA was observed in cases with PAN-like arteritis compared to those without (4/5 vs 8/25), similar to the findings for MPO-ANCA in glomerulonephritis. The crude odds ratio of MPO-ANCA positivity for both glomerulonephritis and PAN-like arteritis was 8.50 (95% CI: 1.05–181.45). The optimal IgE thresholds for detecting cutaneous vasculitis and cardiomyopathy were 1860 IU/mL and 2465 IU/mL, respectively, with areas under the curve of 0.82 and 0.84, indicating favorable diagnostic performance.

Conclusions

IgE levels were associated with cutaneous vasculitis and cardiomyopathy in an inception cohort of EGPA in Japan. Further studies with larger cohorts are needed to confirm these findings, as our results are based on a retrospective study with a small sample size.

Key Points

• IgE levels were associated with cutaneous vasculitis in EGPA.

• IgE levels were associated with cardiomyopathy in EGPA.

• PAN-like arteritis tended to be associated with MPO-ANCA positivity.